Liraglutide Injection Suppliers & Bulk Manufacturers

Available Forms: Pre filled Pen

Available Strengths: 6 mg/mL

Reference Brands: Saxenda®(US & EU)

Category: Diabetes

Saxenda® mimics GLP-1 to enhance satiety, delay gastric emptying, and reduce calorie intake. It promotes weight loss by regulating appetite and metabolism. Clinically proven for chronic weight management, it helps patients achieve significant BMI reduction. Benefits include improved metabolic parameters and potential cardiovascular protection. Administered once daily via subcutaneous injection. Liraglutide injection is available in Pre filled Pen and strengths such as 6 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Liraglutide injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Liraglutide injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Saxenda® (liraglutide 3 mg), a GLP-1 receptor agonist, is FDA-approved for chronic weight management in adults (BMI ≥30 or ≥27 with comorbidities) and adolescents (12+). The EMA approves it for adults only, with similar BMI criteria. Both regulators mandate a boxed warning for thyroid C-cell tumor risk and contraindicate use in patients with personal/family history of MTC or MEN 2. Discontinue if <5% weight loss occurs after 12 weeks. Storage: Refrigerate (2–8°C); stable at ≤30°C (USA) or ≤25°C (EU) post-opening. Platforms like Pharmatradz.com streamline global B2B access to compliant Saxenda® sourcing and licensing.